Huili Zhu (@huilizhu) 's Twitter Profile
Huili Zhu

@huilizhu

GI medical oncologist @MDAndersonNews. Passionate about uncovering genomic etiology and developing targeted treatment options.

ID: 3224818509

calendar_today30-04-2015 17:11:03

11 Tweet

101 Followers

162 Following

Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

Fantastic discussion going on the Rapid Abstracts session A. Weโ€™re talking about the amazing health services based research presented ASCO #ascoqlty22 with Drs Ryan Nipp, MD, MPH, MBA, FASCO Huili Zhu Fauzia Riaz, MD, MHS Cristiane D Bergerot Regina Barragan-Carrillo and Jensen ๐Ÿ™Œ๐Ÿ™Œ๐Ÿ™Œ๐Ÿ™Œ

Fantastic discussion going on the Rapid Abstracts session A. Weโ€™re talking about the amazing health services based research presented <a href="/ASCO/">ASCO</a> #ascoqlty22 with Drs <a href="/RyanNipp/">Ryan Nipp, MD, MPH, MBA, FASCO</a> <a href="/HuiliZhu/">Huili Zhu</a> <a href="/FauziaRiaz/">Fauzia Riaz, MD, MHS</a> <a href="/crisbergerot/">Cristiane D Bergerot</a> <a href="/ReginaBarCar/">Regina Barragan-Carrillo</a> and Jensen ๐Ÿ™Œ๐Ÿ™Œ๐Ÿ™Œ๐Ÿ™Œ
Huili Zhu (@huilizhu) 's Twitter Profile Photo

Excited to share our work on โ€œIdentification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smokingโ€, published today in JCO Precision Oncology JCO Precision Oncology ascopubs.org/doi/10.1200/POโ€ฆ

Deborah Doroshow (@ddoroshow) 's Twitter Profile Photo

Many institutions disallow or limit ICIs for hospitalized pts w/cancer because they have to eat the cost. But what about clinical benefits? Our group examined clinical outcomes of pts treated with inpatient ICIs at 5 large academic institutions. ascopubs.org/doi/10.1200/OPโ€ฆ

Many institutions disallow or limit ICIs for hospitalized pts w/cancer because they have to eat the cost. But what about clinical benefits? Our group examined clinical outcomes of pts treated with inpatient ICIs at 5 large academic institutions. ascopubs.org/doi/10.1200/OPโ€ฆ